🇺🇸 FDA
Patent

US 10265338

Compounds and methods for treating neurological and cardiovascular conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 10265338 (Compounds and methods for treating neurological and cardiovascular conditions) held by The Board of Regents of the University of Texas System expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P25/00